Mark T Wagner insider trades: Alliqua BioMedical (ALQA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 3, 2017 | ALQA | ↑ Buy | 62,500 | $0.40 | $25K | Direct | Apr 4, 2017 (1d) |
| Nov 6, 2015 | ALQA | ↑ Buy | 8,000 | $2.88 | $23K | Direct | Nov 9, 2015 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark T Wagner's insider trades
Mark T Wagner is a director at Alliqua BioMedical (ALQA). Since Nov 6, 2015, Mark has reported 2 open-market purchases worth $48K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), other transactions (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALQA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.